Back to search

National and Kapodistrian University of Athens

Ανάπτυξη μη επεμβατικής προγεννητικής διαγνωστικής μεθόδου για την ανίχνευση της β-θαλασσαιμίας στον κυπριακό πληθυσμό

Abstract

dc:description

β-thalassaemia is one of the commonest autosomal recessive single-gene disorders in Cyprus with about 14% of the population being carriers. Seven different beta-thalassaemia mutations account for over 98% of all cases with the mutation IVSI-110 representing the 79.8% of the total 7 different mutations. Prenatal diagnosis of β-thalassemia is mainly based on chorionic villus sampling done at the 11th week of gestation and amniocentesis done on the 15th week of gestation. Both procedures are invasive and pose an abortion risk to the fetus as well as psychological discomfort and distress.The recent discovery of cell free fetal DNA in the maternal circulation during pregnancy in combination with molecular techniques for the analysis of genetic markers has opened up new avenues for the non invasive prenatal diagnosis. Concerted effort was directed towards studying the presence of fetal genetic material in the maternal circulation and its use for a reliable and convenient non-invasive prenatal diagnosis. The fact that fetal DNA represents a minor population in maternal plasma comprising only up to 10% of free DNA, is highly fragmented and not a lot is known about the fetal DNA properties poses a technical challenge for the scientist making his detection difficult. The major aim of the present thesis is the development of a non invasive prenatal method for the diagnosis of β-thalassaemia with the detection of the paternally inherited alleles of the fetus in the maternal plasma of at risk pregnancies for β-thalassaemia. The approach is based on the analysis of SNPs located on the β-globin gene cluster. For the detection of the paternally inherited allele different techiniques have been investigated, such as AS-RTPCR, APEX microarrays/thalassochip and targeted next generation sequencing with the Illumina platform and PNA probes in combination with automated sequencing. For the determination of the most suitable approach for the isolation of fetal DNA in the plasma, a comparative parallel study has been performed with the Qiagen kits QIAamp DNA Blood Mini Kit and QIAamp DSP Virus kit. The later one gave the best results and therefore was used for the major part of this study. In subsequent studies the new Qiagen kit QIAamp circulating nucleic acid kit, was evaluated for its performance and it was shown to give even better results, therefore was used during the last part of this study.During the first stages of the study, the PCR method for the Y chromosome detection in the maternal plasma samples from male pregnancies was used for the confirmation of the presence of fetal material in the samples and as a tool for the standardization of the fetal detection in the maternal plasma during the process of the development of a NIPD method of β-thalassaeimia. Moreover, it was used as an internal control for the positive detection of fetal DNA. The identification of SNPs that will be used for the development of NIPD was performed as follows: For the determination of high heterozygote SNPs, genotyping analysis was performed on 75 random samples from the Greek Cypriot population on 140 SNPs located on the β-globin gene cluster. The SNPs with high heterozygosity were evaluated on 101 carrier couples for the determination of their suitability in NIPD. 49 SNPs with higher than 10% heterozygosity were therefore selected for their assessment as markers for NIPD of β-thalassaemia and for the determination of the number of families that will be benefited by NIPD by assigning the informative SNPs per family. The evaluation showed that 72.27% of the families have at least three informative SNPs, thus fulfilling the criteria for an accurate NIPD. One of the approaches that were used for the development of NIPD of β-thalassaemia was the Allele Specific Real Time PCR. The sensitivity and specificity of the method was determined for the SNP rs10837631 using genomic DNA where the minor allele was detected. The method was applied on maternal plasma samples for the same SNP where the expected detection of the paternally inherited allele was observed. However, the sensitivity of the approach was not the expected one therefore it was decided to abandon the method.The second method that was explored for the development of NIPD was the Arrayed Primer EXtension (APEX) assay, a microarray based assay that utilizes a chip called Thalassochip. Twenty one SNPs were selected to be placed on the thalassochip and evaluated for their suitability to be analyzed for NIPD. After the evaluation, the final thalssochip contained 18 SNPs. The sensitivity and specificity of the method was determined using genomic DNA. The method was applied on maternal plasma samples from mothers at risk for β-thalassaemia in their fetus. First, 34 maternal plasma samples were analyzed for 3 informative SNPs. It was observed that 79.3% gave the correct result while there was 1 false negative detection and 5 false positive detection of the paternally inherited allele. In a later stage, 10 families that had 2 to 6 informative SNPs were analyzed. From the results obtained, the paternal allele was succesfully detected in 18 cases out of 30 analyzed (60%). However, false negative detection was also observed in 5 (16.7%) cases and false potive detection in 7 (23.3%) cases. With the APEX approach, the paternally inherited allele was possible, presenting however, technical problems. Improvement of the method was not possible despite all the effort, therefore, it was decided to search for alternative approaches. In an attempt to identify efficient methodologies for the the maternal plasma analysis, alternative approaches were searched for the selective enrichment of the fetal allele, such as PNAs. The efficacy of PNAs was evaluated where the suppresion of the major allele and the enrichment of the minor allele was observed in one SNP while false positive detection was observed in the other SNP. However, the assessment of the optimal PNA concentration which needs to be established for each mutation per sample in combination with the high cost of the probe make the approach difficult to be applied for routine analysis and large scale clinical applications. Therefore, it was decided not to pursue the approach. The analytical power and the specificity of a modified version of NGS using the Illumina platform called ‘targeted sequencing’ was assessed for the development of NIPD. A preliminary study was done using 5 SNPs where the detection of the paternally inherited allele was achieved for 3 SNPs. Subsequently, the specificity of the platform to detect and differentiate the minor allele present in the overwhelming background of the maternal allele was confirmed using spiked genomic samples. The reliability of the method was assessed with the analysis of maternal plasma samples from 10 families having 3 to 4 informative SNPs. From 34 samples analysed, the paternal allele in the maternal plasma was positively detected and differentiated in 8 of the cases whereas in 18 cases no other measurable allele was observed (negative detection of the paternal allele). However, 4 false positive and 4 false negative results were also observed. Overall, the sequencing platform showed 81.8% specificity and 66.7% sensitivity with false positive rate 0.18% for the detection of the fetal allele in the maternal plasma. In conclusion, this study showed for the first time that the detection of the paternally inherited allele in the maternal plasma is possible with the targeted next generation sequencing with SNP analysis. Further studies are necessary for the improvement of the method and for the elimination of false positive and false negative results. To investigate the feasibility of SNPs for the NIPD of β-thalassaemia analysed by Illumina sequencing of the maternal plasma, haplotype analysis was performed. Haplotype analysis based on the results obtained was performed and NIPD was made for 7 out of 10 families. The importance of having a high number of SNPs for each family in order to eliminate the diagnostic error was illustrated in all cases.In summary, we reach the following conclusions:1.The importance of having a high number of SNPs for each family was highly illustrated in all methods used in this method. A higher number of multiple SNPs per sample analysed will improve the sensitivity and accuracy of NIPD and eliminate the diagnostic error. It was clearly demonstrated, therefore, that analysis on higher number of SNPs will markedly increase the statistical power to differentiate the maternal from the paternal allele through haplotype analysis with a higher level of accuracy and for a greater proportion of carrier couples.2.The detection of fetal alleles of paternal origin in the maternal plasma and NIPD was possible with the above methods. Sensitivity and specificity problems as well as false positives were observed that need substantial improvement. 3.Next Generation Sequencing shows the greatest accuracy and precision for the differentiation and detection of the fetal alleles of paternal origin and is currently the main technological platform used for the maternal plasma analysis for NIPD. 4.The detection of the paternally inherited allele applies only to the 50% of the cases where the fetus inherits the normal allele of the father. In the future, one should look for other approaches using this technology for deducing the maternally inherited allele as well with the use of an adapted method of the relative mutation dosage approach (RMD).Data derived from the present study can contribute towards an effective approach for the NIPD of β-thalassaemia. Directions for future development would be to improve the diagnostic efficiency, precision, accuracy and reliability of targeted next generation sequencing by eliminating the false positives and false negative results obtained by inclusion of a higher number of samples with more replicates. Using a higher number of multiple SNPs per sample analysed will improve the sensitivity and accuracy of NIPD.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papasavva, Thessalia
  • Παπασάββα-Ρούσου, Θεσσαλία

Subjects

dc:subject × 15

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29587

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papasavva, Thessalia; Παπασάββα-Ρούσου, Θεσσαλία. Ανάπτυξη μη επεμβατικής προγεννητικής διαγνωστικής μεθόδου για την ανίχνευση της β-θαλασσαιμίας στον κυπριακό πληθυσμό. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/29587